Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
IGM Biosciences, Inc.
IGM Biosciences, Inc.
Western Regional Medical Center
National Health Research Institutes, Taiwan
Dartmouth-Hitchcock Medical Center
Emory University
Case Comprehensive Cancer Center